Literature DB >> 12742921

Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis.

Wayne D Hall1, Andrea Mant, Philip B Mitchell, Valerie A Rendle, Ian B Hickie, Peter McManus.   

Abstract

OBJECTIVE: To examine the association between trends in antidepressant prescribing and suicide rates in Australia for 1991-2000.
DESIGN: Analysis of databases of suicide and rates of antidepressant prescribing according to age and sex.
SETTING: Australian Bureau of Statistics data, sales data from the Australian pharmaceutical industry, prescribing data in general practice.
SUBJECTS: Men and women aged 15 years and over in 10 year age groups. MAIN OUTCOME MEASURES: Trends in suicide rates and trends in antidepressant prescribing. Association measured by Spearman's rank correlations.
RESULTS: While overall national rates of suicide did not fall significantly, incidence decreased in older men and women and increased in younger adults. In both men (r(s)=-0.91; P<0.01) and women (r(s)=-0.76; P<0.05) the higher the exposure to antidepressants the larger the decline in rate of suicide.
CONCLUSIONS: Changes in suicide rates and exposure to antidepressants in Australia for 1991-2000 are significantly associated. This effect is most apparent in older age groups, in which rates of suicide decreased substantially in association with exposure to antidepressants. The increase in antidepressant prescribing may be a proxy marker for improved overall management of depression. If so, increased prescribing of selective serotonin reuptake inhibitors in general practice may have produced a quantifiable benefit in population mental health.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742921      PMCID: PMC154757          DOI: 10.1136/bmj.326.7397.1008

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  13 in total

1.  Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates.

Authors:  C Barbui; A Campomori; B D'Avanzo; E Negri; S Garattini
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1999-03       Impact factor: 4.328

2.  Suicide prevention--a medical breakthrough?

Authors:  G Isacsson
Journal:  Acta Psychiatr Scand       Date:  2000-08       Impact factor: 6.392

3.  Epidemiological data suggest antidepressants reduce suicide risk among depressives.

Authors:  G Isacsson; U Bergman; C L Rich
Journal:  J Affect Disord       Date:  1996-11-04       Impact factor: 4.839

4.  General practice audit as a quality assurance activity. An evaluation of the Morbidity and Therapeutic Index.

Authors:  S Vagholkar; J Spencer; J Charles
Journal:  Aust Fam Physician       Date:  1996-03

5.  Treatment of common mental disorders in Australian general practice.

Authors:  I B Hickie; T A Davenport; S L Naismith; E M Scott; D Hadzi-Pavlovic; A Koschera
Journal:  Med J Aust       Date:  2001-07-16       Impact factor: 7.738

6.  Effects of mental health training and clinical audit on general practitioners' management of common mental disorders.

Authors:  S L Naismith; I B Hickie; E M Scott; T A Davenport
Journal:  Med J Aust       Date:  2001-07-16       Impact factor: 7.738

Review 7.  Can better recognition and treatment of depression reduce suicide rates? A brief review.

Authors:  Z Rihmer
Journal:  Eur Psychiatry       Date:  2001-11       Impact factor: 5.361

8.  Public beliefs about the helpfulness of interventions for depression: effects on actions taken when experiencing anxiety and depression symptoms.

Authors:  A F Jorm; J Medway; H Christensen; A E Korten; P A Jacomb; B Rodgers
Journal:  Aust N Z J Psychiatry       Date:  2000-08       Impact factor: 5.744

9.  Recent trends in the use of antidepressant drugs in Australia, 1990-1998.

Authors:  P McManus; A Mant; P B Mitchell; W S Montgomery; J Marley; M E Auland
Journal:  Med J Aust       Date:  2000-11-06       Impact factor: 7.738

10.  Newer antidepressants: a comparison of tolerability in general practice.

Authors:  F R Mackay; N R Dunn; R M Martin; G L Pearce; S N Freemantle; R D Mann
Journal:  Br J Gen Pract       Date:  1999-11       Impact factor: 5.386

View more
  60 in total

Review 1.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Antidepressant prescribing and suicide: Analysis is misleading.

Authors:  Joanna Moncrieff
Journal:  BMJ       Date:  2003-08-02

3.  Antidepressant prescribing and suicide: Antidepressants do not reduce suicide rates.

Authors:  Peter H Ankarberg
Journal:  BMJ       Date:  2003-08-02

4.  Antidepressant prescribing and suicide: Decline in suicide rate among older people predates 1991.

Authors:  Thomas J Verberne
Journal:  BMJ       Date:  2003-08-02

5.  Antidepressant prescribing and suicide: Associations attribute possible causality inappropriately.

Authors:  Brian M Draper
Journal:  BMJ       Date:  2003-08-02

Review 6.  Antidepressants and suicide: what is the balance of benefit and harm.

Authors:  David Gunnell; Deborah Ashby
Journal:  BMJ       Date:  2004-07-03

Review 7.  Risk of adverse behavioral effects with pediatric use of antidepressants.

Authors:  Wayne K Goodman; Tanya K Murphy; Eric A Storch
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

8.  Divergent trends in suicide by socio-economic status in Australia.

Authors:  Andrew Page; Stephen Morrell; Richard Taylor; Greg Carter; Michael Dudley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-01       Impact factor: 4.328

9.  US suicide rates by age group, 1970-2002: an examination of recent trends.

Authors:  Robert E McKeown; Steven P Cuffe; Richard M Schulz
Journal:  Am J Public Health       Date:  2006-10       Impact factor: 9.308

10.  Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

Authors:  D N Bateman; J Chick; A M Good; C A Kelly; G Masterton
Journal:  Eur J Clin Pharmacol       Date:  2004-04-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.